A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complex.
Xu XN, Purbhoo MA, Chen N, Mongkolsapaya J, Cox JH, Meier UC, Tafuro S, Dunbar PR, Sewell AK, Hourigan CS, Appay V, Cerundolo V, Burrows SR, McMichael AJ, Screaton GR.
Xu XN, et al. Among authors: mcmichael aj.
Immunity. 2001 May;14(5):591-602. doi: 10.1016/s1074-7613(01)00133-9.
Immunity. 2001.
PMID: 11371361
Free article.